At a glance
ClinicalIndex Comparison RecordN/ACompleted· 15 enrolled
Drug / intervention
RF Treatmentdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
RAFA Trial: Radiofrequency Ablation of Adenomyosis
University of Texas Southwestern Medical Center·interventional·Posted Nov 23, 2021·Updated Mar 20, 2026
In Brief
A clinical study evaluating RF Treatment for Adenomyosis. Completed, enrolled 15 participants across 1 site.
Detailed Summary
To observe the effects of radiofrequency ablation on adenomyosis through the pathological analysis of treated tissue that has been removed during planned hysterectomy.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAdenomyosis
CountriesUnited States
CollaboratorsHologic, Inc.
Timeline
N/ACompletedFinished
20222023202420252026
First PostedNov 2021
Enrollment StartJul 2022
Primary CompletionJan 2025
TodayJul 2026
First PostedNov 23, 2021
Enrollment StartJul 14, 2022
Primary CompletionJan 22, 2025
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 4.6 years ago
Interventions
RF Treatmentdevice
ProVu treatment probe will be energized and RF energy delivered in a pre-programmed, controlled method based on the predetermined size of the affected tissue.